Corpus Intelligence IC Memo — PARKLAND MEDICAL CENTER 2026-04-27 03:04 UTC
IC Memo — PARKLAND MEDICAL CENTER
Investment Committee Memorandum | NH | 68 beds | Grade C | EBITDA uplift $11.7M
🛡️ Public data only — no PHI permitted on this instance.
INVESTMENT COMMITTEE MEMORANDUM  ·  CCN 300017

PARKLAND MEDICAL CENTER

LOCATIONROCKINGHAM, NH·BEDS68·AS OFApril 27, 2026
C
INVESTABILITY
EBITDA BridgeData Room

1. Target Overview & Investment Thesis

PARKLAND MEDICAL CENTER is a 68-bed suburban community hospital in ROCKINGHAM, NH with $158.7M in net patient revenue and a 47.2% operating margin. The hospital serves a payer mix of 42.5% Medicare, 1.4% Medicaid, and 56.1% commercial.

Thesis: Turnaround. Our ML models identify $11.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 47.2% to 54.6% (+736bps).

Net Revenue HCRIS$158.7M
Current EBITDA COMPUTED$74.9M
Operating Margin COMPUTED47.2%
Occupancy HCRIS60.7%
Revenue / Bed COMPUTED$2.3M
Net-to-Gross HCRIS17.0%
Distress Probability ML42.4%

2. Market Context & Competitive Position

30
NH Hospitals
-2.7%
State Median Margin
8
Comparable Hospitals

NH has 30 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of 47.2% places it above the state median. Among 8 size-comparable peers (34-136 beds), the median margin is -3.2%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (34-136), prioritizing same-state peers. 8 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PARKLAND MEDICAL CENTER (Target)NH68$158.7M47.2%
WENTWORTH DOUGLASS HOSPITALNH118$500.9M10.7%
EXETER HOSPITAL INC.NH99$282.0M-3.2%
CHESHIRE MEDICAL CENTERNH86$236.2M-22.4%
CONCORD HOSPITAL - LACONIANH86$131.9M-12.6%
NORTHEAST REHABILITATION HOSPINH135$102.7M-0.2%
FRISBIE MEMORIAL HOSPITALNH58$71.7M-27.5%
ENCOMPASS HEALTH REHABILITATIONH50$31.9M26.0%
HAMPSTEAD HOSPITALNH72$nannan%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.3M+210bp18mo
Cost to Collect4.5%2.5%$3.2M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.1M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.9M+122bp9mo
Clean Claim Rate88.0%96.0%$102K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.3M
Cost to Collect
$3.2M
Denial Rate Reduction
$3.1M
A/R Days Reduction
$1.9M
Clean Claim Rate
$102K
Total EBITDA Uplift$11.7M
Current EBITDA$74.9M
+ RCM Uplift+$11.7M
Pro Forma EBITDA$86.6M
Current Margin47.2%
Pro Forma Margin54.6%
WC Released (1x)$6.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$115.3M$611.2M5.30x39.6%
Base (11x exit)10.0x11.0x$115.3M$709.7M6.16x43.8%
Bull Case9.0x11.0x$103.8M$785.7M7.57x49.9%
Bull (12x exit)9.0x12.0x$103.8M$887.8M8.56x53.6%
Bear Case11.0x10.0x$126.8M$515.3M4.06x32.4%
Bear (11x exit)11.0x11.0x$126.8M$608.0M4.79x36.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 8 hospitals with 34-136 beds
  • Same-state prioritization (n=9)
  • Comp margins: P25=-17.5% / P50=-3.2% / P75=5.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.